Tetrous

Tetrous, Inc. is a regenerative medicine company based in Sherman Oaks, California, founded in 2019. The company specializes in advanced technologies for enthesis repair, focusing on the tendon-to-bone interface, which is vital in sports medicine and orthopedic surgery. Their core technology, adapted from spine surgery applications, has been utilized in nearly 100,000 procedures. The flagship product line, EnFix, includes demineralized cortical bone fiber implants designed to enhance healing at the enthesis. The first product, EnFix RC™, specifically targets rotator cuff repair, addressing challenges in tendon-to-bone healing. These implants promote bone and tendon regeneration and feature FormLok™ technology to maintain shape during arthroscopic surgery. Tetrous holds multiple U.S. patents related to these implants, providing a competitive edge in the market. Tetrous is actively expanding its applications and clinical data to improve patient outcomes in orthopedic surgeries involving various joints. The company has established distribution partnerships in the United States, Australia, and New Zealand, supporting its growth and market presence.

• Employees 7
• Founded 2019